Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

310 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Liposomal prostaglandin E1 (TLC C-53) in acute respiratory distress syndrome: a controlled, randomized, double-blind, multicenter clinical trial. TLC C-53 ARDS Study Group.
Abraham E, Baughman R, Fletcher E, Heard S, Lamberti J, Levy H, Nelson L, Rumbak M, Steingrub J, Taylor J, Park YC, Hynds JM, Freitag J. Abraham E, et al. Among authors: heard s. Crit Care Med. 1999 Aug;27(8):1478-85. doi: 10.1097/00003246-199908000-00013. Crit Care Med. 1999. PMID: 10470753 Clinical Trial.
Effect of Esophageal Pressure-guided Positive End-Expiratory Pressure on Survival from Acute Respiratory Distress Syndrome: A Risk-based and Mechanistic Reanalysis of the EPVent-2 Trial.
Sarge T, Baedorf-Kassis E, Banner-Goodspeed V, Novack V, Loring SH, Gong MN, Cook D, Talmor D, Beitler JR; EPVent-2 Study Group. Sarge T, et al. Am J Respir Crit Care Med. 2021 Nov 15;204(10):1153-1163. doi: 10.1164/rccm.202009-3539OC. Am J Respir Crit Care Med. 2021. PMID: 34464237 Free PMC article. Clinical Trial.
Bronchopulmonary segmental lavage with Surfaxin (KL(4)-surfactant) for acute respiratory distress syndrome.
Wiswell TE, Smith RM, Katz LB, Mastroianni L, Wong DY, Willms D, Heard S, Wilson M, Hite RD, Anzueto A, Revak SD, Cochrane CG. Wiswell TE, et al. Among authors: heard s. Am J Respir Crit Care Med. 1999 Oct;160(4):1188-95. doi: 10.1164/ajrccm.160.4.9808118. Am J Respir Crit Care Med. 1999. PMID: 10508806 Clinical Trial.
Patients received one of three dosing regimens in which aliquots of Surfaxin were administered via a wedged bronchoscope to each of the 19 bronchopulmonary segments. Suctioning was performed 10-30 s after instillation of individual aliquots. Group 1 patients (n = 3) receiv …
Patients received one of three dosing regimens in which aliquots of Surfaxin were administered via a wedged bronchoscope to each of the 19 b …
Effect of prophylactic administration of recombinant human granulocyte colony-stimulating factor (filgrastim) on the frequency of nosocomial infections in patients with acute traumatic brain injury or cerebral hemorrhage. The Filgrastim Study Group.
Heard SO, Fink MP, Gamelli RL, Solomkin JS, Joshi M, Trask AL, Fabian TC, Hudson LD, Gerold KB, Logan ED. Heard SO, et al. Crit Care Med. 1998 Apr;26(4):748-54. doi: 10.1097/00003246-199804000-00027. Crit Care Med. 1998. PMID: 9559614 Clinical Trial.
An evaluation of the hemodynamic effects of HA-1A human monoclonal antibody.
Kett DH, Quartin AA, Sprung CL, Fisher CJ Jr, Peña MA, Heard SO, Zimmerman JL, Albertson TE, Panacek EA, Eidelman LA, et al. Kett DH, et al. Among authors: heard so. Crit Care Med. 1994 Aug;22(8):1227-34. doi: 10.1097/00003246-199408000-00005. Crit Care Med. 1994. PMID: 8045141 Clinical Trial.
310 results